| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.056 | 0.2 |